NCT05447923

Brief Summary

This clinical trial studies disparities involving colorectal cancer prevention and screening in Black and underserved communities in the Phoenix metropolitan area. The Black community is disproportionately impacted by colorectal cancer, with the highest rate of any racial/ethnic group in the United States. There are complex reasons behind these disparities, largely related to socioeconomic factors and healthcare access. Providing access to free, home-based fecal immunochemical testing (FIT), colorectal screening education, and appropriate follow-up to predominantly Black community-based organizations and underserved communities may help to close this gap.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
450

participants targeted

Target at P75+ for not_applicable

Timeline
50mo left

Started May 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
May 2022Jun 2030

Study Start

First participant enrolled

May 22, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 28, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 7, 2022

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2030

Last Updated

April 2, 2026

Status Verified

April 1, 2026

Enrollment Period

8 years

First QC Date

June 28, 2022

Last Update Submit

April 1, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Colorectal cancer disparities seen in people of color and minority populations

    Evaluate patient navigation to address colorectal cancer disparities seen in people of color, minority populations, and establish an ongoing colorectal cancer screening outreach program.

    Up to study completion, up to 30 days

Study Arms (1)

Screening (FIT, education, questionnaire, patient navigation)

EXPERIMENTAL

Participants receive free FIT tests in conjunction with education on colorectal cancer screening. Participants undergo self-collect FIT and mail the sample to Mayo Clinic Lab for processing. Participants also complete a questionnaire about colorectal cancer screening and healthcare. Participants receive FIT test results through Mayo Clinic nursing support and participants with a positive test are followed up by a patient navigator to discuss next steps and consultation with a gastroenterologist to review their results.

Other: Educational InterventionOther: Fecal Immunochemical TestBehavioral: Patient NavigationOther: Questionnaire Administration

Interventions

Undergo education for colorectal cancer screening

Also known as: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational
Screening (FIT, education, questionnaire, patient navigation)

Undergo FIT testing

Also known as: FIT, iFOBT, immunoassay fecal occult blood test, immunochemical fecal occult blood test, Immunochemical FOBT, immunologic fecal occult blood test
Screening (FIT, education, questionnaire, patient navigation)

Undergo patient navigation for positive FIT results

Also known as: Patient Navigator Program
Screening (FIT, education, questionnaire, patient navigation)

Complete questionnaire about colorectal cancer screening and healthcare

Screening (FIT, education, questionnaire, patient navigation)

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 45 years of age or older
  • No prior history of colorectal cancer or colon polyps
  • No first-degree family history of colorectal cancer who were diagnosed under age 60
  • No current gastrointestinal (GI) or rectal symptoms (such as rectal bleeding)
  • Have not undergone a colonoscopy in the last 5 years
  • Have not had a fecal immunochemical test (FIT) test within the last year
  • Participants that attend 4 predominantly African American churches within the Phoenix Community and extend the study opportunity as feasible to other underserved communities in the Phoenix Metro area

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Arizona

Scottsdale, Arizona, 85259, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Colorectal Neoplasms

Interventions

Early Intervention, EducationalEducational StatusMethodsPatient Navigation

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Child Health ServicesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPreventive Health ServicesSocioeconomic FactorsPopulation CharacteristicsInvestigative TechniquesPatient-Centered CarePrimary Health CareComprehensive Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Juliana M. Kling, MD, MPH

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yahaira J. Parker

CONTACT

Clinical Trials Referral Office

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2022

First Posted

July 7, 2022

Study Start

May 22, 2022

Primary Completion (Estimated)

June 1, 2030

Study Completion (Estimated)

June 1, 2030

Last Updated

April 2, 2026

Record last verified: 2026-04

Locations